Zusammenfassung
In diesem Artikel soll eine Übersicht über wichtige, publizierte Arbeiten auf dem Gebiete der Therapie mit dem implantierbaren Kardioverter/Defibrillator (ICD) im Jahre 2012 gegeben werden. Wesentliche Arbeiten betrafen Analysen zur Therapieeffektivität und -sicherheit des subkutan implantierbaren ICD, zu geschlechtsspezifischen Unterschieden in der Komplikationsrate und Prognose nach ICD-Implantation, zur Notwendigkeit der intraoperativen Testung der Defibrillationsschwelle und zur Beeinflussung der Prognose nach ICD-Implantation durch Verhinderung von ICD-Schockentladungen. Die Relevanz der Studienergebnisse für den klinischen Alltag wird jeweils kurz diskutiert.
Abstract
This article aims to give an overview over important articles in the field of implantable cardioverter defibrillator (ICD) therapy in 2012. Important publications concern analyses on therapy efficacy and safety of the subcutaneous ICD, gender-specific differences in the complication rate and prognosis after ICD implantation, the necessity of intraoperative testing of the defibrillation threshold and the impact of preventive measures to reduce ICD therapies on prognosis after device implantation. The relevance of the study findings for daily clinical practice is briefly discussed.
Literatur
Aydin A, Hartel F, Schlüter M, Butter C, Köbe J, Seifert M, Gosau N, Hoffmann B, Hoffmann M, Vettorazzi E, Wilke I, Wegscheider K, Reichenspurner H, Eckardt L, Steven D, Willems S (2012) Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience. Circ Arrhythm Electrophysiol 5(5):913–919
Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, Theuns D, Park RE, Wright DJ, Connelly DT, Fynn SP, Murgatroyd FD, Sperzel J, Neuzner J, Spitzer SG, Ardashev AV, Oduro A, Boersma L, Maass AH, Van Gelder IC, Wilde AA, van Dessel PF, Knops RE, Barr CS, Lupo P, Cappato R, Grace AA (2010) An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med 363(1):36–44
Brignole M, Occhetta E, Bongiorni MG, Proclemer A, Favale S, Iacopino S, Calò L, Vado A, Buja G, Mascioli G, Quartieri F, Tritto M, Parravicini U, Castro A, Tomasi C, Villani GQ, D’Acri MG, Klersy C, Gasparini M, SAFE-ICD Study Investigators (2012) Clinical evaluation of defibrillation testing in an unselected population of 2,120 consecutive patients undergoing first implantable cardioverter-defibrillator implant. J Am Coll Cardiol 60(11):981–987
Crossley GH, Boyle A, Vitense H, Chang Y, Mead RH, for the CONNECT Investigators The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) Trial. (2011) The value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol 57:1181–1189
Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S, Machado C (2009) Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Arch Intern Med 169(16):1500–1506
Gold MR, Theuns DA, Knight BP, Sturdivant JL, Sanghera R, Ellenbogen KA, Wood MA, Burke MC (2012) Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study. J Cardiovasc Electrophysiol 23(4):359–366
Ha AH, Ham I, Nair GM, Connolly SJ, Dorian P, Morillo CA, Healey JS (2012) Implantable cardioverter-defibrillator shock prevention does not reduce mortality: a systemic review. Heart Rhythm 9:2068–2074
Healey JS, Gula LJ, Birnie DH, Sterns L, Connolly SJ, Sapp J, Crystal E, Simpson C, Exner DV, Kus T, Philippon F, Wells G, Tang AS (2012) A randomized-controlled pilot study comparing ICD implantation with and without intraoperative defibrillation testing in patients with heart failure and severe left ventricular dysfunction: a substudy of the RAFT trial. J Cardiovasc Electrophysiol 23(12):1313–1316
Landolina M, Perego GB, Lunati M, Curnis A, Guenzati G, Vicentini A, Parati G, Borghi G, Zanaboni P, Valsecchi S, Marzegalli M (2012) Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators. The evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study. Circulation 125:2985–2992
Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NA 3rd, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W, MADIT-RIT Trial Investigators (2012) Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 367(24):2275–2283
Olde Nordkamp LR, Dabiri Abkenari L, Boersma LV, Maass AH, de Groot JR, van Oostrom AJ, Theuns DA, Jordaens LJ, Wilde AA, Knops RE (2012) The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. J Am Coll Cardiol 60(19):1933–1939
Olde Nordkamp LR, Knops RE, Bardy GH, Blaauw Y, Boersma LV, Bos JS, Delnoy PP, van Dessel PF, Driessen AH, de Groot JR, Herrman JP, Jordaens LJ, Kooiman KM, Maass AH, Meine M, Mizusawa Y, Molhoek SG, van Opstal J, Tijssen JG, Wilde AA (2012) Rationale and design of the PRAETORIAN trial: a prospective, randomized comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy. Am Heart J 163(5):753–760
Pedersen SS, Lambiase P, Boersma LV, Murgatroyd F, Johansen JB, Reeve H, Stuart AG, Adragao P, Theuns DA (2012) Evaluation of factors impacting clinical outcome and cost effectiveness of the S-ICD: design and rationale of the EFFORTLESS S-ICD Registry. Pacing Clin Electrophysiol 35(5):574–579
Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH (2008) Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359(10):1009–1017
Russo AM, Daugherty SL, Masoudi FA, Wang Y, Mazzarelli J, Curtis J, Lampert R (2012) Gender and outcomes following primary prevention ICD placement: analysis of the NCDR ICD registry. Circulation 126:A9310
Santangeli P, Pelargonio G, Dello Russo A, Casella M, Bisceglia C, Bartoletti S, Santarelli P, Di Biase L, Natale A (2010) Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis. Heart Rhythm 7(7):876–882
Saxon LA, Hayes DL, Gilliam FR, Heidenreich PA, Day J, Seth M, Meyer TE, Jones PW, Boehmer JP (2010) Long-term outcome after ICD and CRT implantation and influence of remote device follow-up. The ALTITUDE survival study. Circulation 122:2359–2367
Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes M, Ferguson TB, Hammill SC, Karasik PE, Link MS, Marine JE, Schoenfeld MH, Shanker AJ, Silka MJ, Stevenson LW, Stevenson WG, Varosy PD (2012) 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 126:1784–1800
Varma N, Michalski J, Epstein AE, Schweikert R (2010) Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance the Lumos-T safely Reduces Routine Office Device Follow-up (TRUST) Trial. Circ Arrhythm Electrophysiol 3:428–436
Interessenkonflikt
Der korrespondierende Autor gibt für sich und seine Koautoren an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stellbrink, ., Andresen, D., Böcker, D. et al. Implantierbarer Kardioverter/Defibrillator. Herzschr Elektrophys 24, 75–78 (2013). https://doi.org/10.1007/s00399-013-0265-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00399-013-0265-7